Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. 8-K Event Material agreement
  3. SC 13D Stake Beneficial Ownership Report
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. SC 13D Stake Beneficial Ownership Report
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Bylaws or fiscal year change · Other events
  15. POS462B Other POS462B
  16. POS EX Other Post-effective Amendment
  17. 424B4 Offering Prospectus
  18. CT ORDER Other Confidential Order
  19. EFFECT Other Notice of Effectiveness
  20. 3 Insider Initial Statement of Ownership

Page 28 of 30 · 587 filings